National Institute of Mental Health (NIMH)’s Post

Hear from the experts on how eye tracking and social orienting can aid in the diagnosis of young autistic children. #AtlantaAutismConsortium #EarliPoint #EyeTracking #Identification #Diagnosis #Autism

Supporting Autistic Individuals to Thrive A capabilities approach toward autism. Once #autisticindividuals, researchers, and clinicians amongst others are equipped with a more accurate understanding of which barriers currently limit autistic individuals from thriving in a particular domain, we should be empowered to start removing those barriers so that growth can be facilitated in that area if desired. https://lnkd.in/eq25i8Tk

Are we comparing apples to oranges here? 🤔🍎🍊 A recent study suggests that higher amounts of intervention may not be more helpful for children on the autism spectrum. This raises a critical question for our community: Are we focusing too much on the quantity of intervention rather than the quality? At Hi Rasmus, we believe it's essential to consider both the quality and quantity of intervention. We provide a flexible platform to deliver the highest quality services. Our mission is to help you keep the focus on the child in front of you. How do we balance the quantity and quality of interventions? How much does quantity matter? Share your thoughts in the comments. https://lnkd.in/g2R-mPkg

The issue here is that ASD assessments are: 👉 being administered by individuals without the clinical knowledge or expertise to assess and identify differential diagnosis. This leads to misdiagnosis, underdiagnosis and overdiagnosis. 👉 being conducted using tools that don’t parallel DSM-5-TR criteria, ie. they are outdated. This also leads to misdiagnosis, underdiagnosis and overdiagnosis.

Today, on World Autism Awareness Day, we are shining a spotlight on our client Cognoa, an early childhood development and pediatric behavioral health company that is dedicated to ensuring early, rapid, and equitable care for pediatric developmental and behavioral health conditions like autism. Join us as we celebrate Cognoa’s incredible work and achievements in transforming the path to care for children with developmental concern and their families. ⬇️ Here’s what they’ve been up to lately: Cognoa’s CEO, Dr. Sharief Taraman, MD, DABPN, DABPM, FAAP, spoke with The Economist’s Natasha Loder about how the company is leveraging responsible AI to streamline the autism diagnosis process for her piece on AI’s ability to improve diagnoses across the healthcare industry. Check out this insightful and comprehensive article for more>> https://lnkd.in/ggteKd77 In an effort to help parents best care for their children, BuzzFeed reached out to pediatricians for a candid discussion about the things they believe every parent should know about their child's health. Dr. Taraman shared his advice to parents, emphasizing the importance of educating themselves on the signs and symptoms of developmental delay and taking immediate action when concerns arise. Check out what he and other pediatricians had to say >> https://lnkd.in/dtmpmRQA Continuing to shine his light as a thought leader, Dr. Taraman wrote a piece for Psychology Today on why, when it comes to pediatric developmental and behavioral health, acting early is everything. Check out his expert advice and insights on the immense benefits of early interventions. >> https://lnkd.in/dgbMvbXg Lastly, Dr. Taraman spoke to Behavioral Health Business about Cognoa’s journey to receiving FDA authorization for Canvas Dx, the company’s flagship autism diagnostic solution, as well as the important role that FDA-regulated devices have in driving clinical adoption, expanding access to care, and creating a more efficient healthcare system for both clinicians and patients. >> https://lnkd.in/g5nXgRag #AutismAwareness #Cognoa #PR #TechPR #HealthTech

The snarky side of me read the headline of this article and said, "duh!" It's not the best article, but the point is made. We are doing a disservice to autistic individuals when they don't get a diagnosis. We have to do better—all of us. We have to advocate for these individuals and that starts with education. When we are educated (and that means listening to the actually autistic community) we can educate and help others and get these individuals the help and services they deserve. https://lnkd.in/gcheFGY5

As a parent I can tell you one of the most frustrating things is knowing that your child has developmental needs, but having to wait many months to get evaluated for a diagnosis. There are supports you can put into place while you wait. This blog is super helpful.

🌍 This World Autism Awareness Day, let's recognize the collective strides and ongoing challenges in supporting individuals with Autism Spectrum Disorder (ASD). As awareness grows, so does our responsibility to foster an environment of understanding, acceptance, and innovation. 🌐 𝗧𝗵𝗲 𝗥𝗼𝗹𝗲 𝗼𝗳 𝗕𝗶𝗼𝗽𝗵𝗮𝗿𝗺𝗮, 𝗥&𝗗, 𝗮𝗻𝗱 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 The biopharma, R&D life sciences, and healthcare industries are pivotal in advancing ASD understanding and treatments. From creating targeted therapies to developing early diagnostic tools, these sectors are crucial in improving quality of life for those on the autism spectrum. 🚀 𝗖𝗮𝗹𝗹𝘀 𝘁𝗼 𝗔𝗰𝘁𝗶𝗼𝗻: 𝙄𝙣𝙣𝙤𝙫𝙖𝙩𝙚 𝙏𝙧𝙚𝙖𝙩𝙢𝙚𝙣𝙩𝙨: Continue developing medications that address both core and associated symptoms of ASD. 𝙀𝙣𝙝𝙖𝙣𝙘𝙚 𝘿𝙞𝙖𝙜𝙣𝙤𝙨𝙩𝙞𝙘𝙨: Prioritize the creation of accessible diagnostic tools for early detection and intervention. 𝘾𝙤𝙡𝙡𝙖𝙗𝙤𝙧𝙖𝙩𝙚 𝙤𝙣 𝙍𝙚𝙨𝙚𝙖𝙧𝙘𝙝: Foster partnerships across academia, healthcare, and industry for a comprehensive approach to ASD. 𝙋𝙧𝙤𝙢𝙤𝙩𝙚 𝙄𝙣𝙘𝙡𝙪𝙨𝙞𝙤𝙣: Support awareness initiatives to ensure societal acceptance and understanding of ASD. 𝙀𝙭𝙥𝙖𝙣𝙙 𝙎𝙪𝙥𝙥𝙤𝙧𝙩 𝙎𝙮𝙨𝙩𝙚𝙢𝙨: Advocate for resources and programs that support individuals with ASD and their families. Commitment to Action We all have a role to play in supporting the autism community. Through innovation, collaboration, and dedication, we can create a more inclusive world where individuals with ASD can thrive. Let’s use our collective expertise and compassion to make a lasting impact. #WorldAutismAwarenessDay #ASD #Inclusion #Innovation #Collaboration #SupportAutism

Breaking Barriers: How Kablooe's D3 Process Transformed Autism Diagnosis We're thrilled to share our latest case study spotlighting our collaboration with EarliTec Diagnostics Inc. Together, we've revolutionized early autism detection with the innovative EarliPoint™ Evaluation device. 🚀 🎯 Device Drivers: The challenge was clear—develop a versatile and stable device to detect autism in young children of varying heights, minimizing the risk of tipping and ensuring accurate evaluations. 💡 Kablooe's Strategy & Solution: Our team embraced the challenge, crafting a stand and case with a knob interface for quick, secure height adjustment. This innovative design prioritized safety and usability without compromising versatility. ✅ Design Outcomes: Thanks to clear communication and seamless collaboration, our partnership with EarliTec resulted in the EarliPoint™ Evaluation device—a game-changer in early autism detection. 🙌 👉 Dive into the full case study to discover how Kablooe's Design Driven Development® approach and EarliTec's vision are making waves in neurodevelopmental disorder diagnosis! https://lnkd.in/gh8K8Yeu #AutismAwareness #MedicalInnovation #DesignDrivenDevelopment #KablooeSuccessStory

Feedback is now open on the draft National Autism Strategy. This draft Strategy has not yet been agreed by Government. Following feedback through this public consultation process the draft Strategy will be further refined and it is expected the final Strategy will be presented to Government by the end of 2024. The draft Strategy includes a vision, guiding principles, outcome areas and commitments. These are the main areas for feedback. Submission close 3pm on 31 May. https://lnkd.in/g4Q9ZtSY